Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-05-24 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
240524 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and explicitly details the number of shares repurchased by UCB NV on Euronext Brussels between May 17, 2024, and May 23, 2024, including transaction dates, quantities, and prices. This activity directly corresponds to the definition of a company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement of this specific corporate action.
2024-05-24 Dutch
140524 - PR Transparency notification Wellington - FINAL.pdf
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Transparency notification' and details a change in shareholding by Wellington Management Group LLP, stating that their holding has crossed the 5% threshold downwards. It references Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings. This type of mandatory disclosure regarding changes in significant ownership stakes directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is the notification itself, not an announcement of a report.
2024-05-17 English
140524 - CdP Notification de transparence Wellington - FINAL.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Notification de transparence Wellington" and explicitly states it is a "Notification de transparence" received by UCB SA from Wellington Management Group LLP. The content details changes in shareholdings, specifically crossing a threshold (5%) related to voting rights, as mandated by Belgian law ("loi du 2 mai 2007 relative à la publicité des participations importantes"). This type of filing, reporting changes in significant share ownership by insiders or major investors, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it pertains to a specific insider/major shareholder transaction.
2024-05-17 French
140524 - PB Transparantieverklaring Wellington - FINAL.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Transparantieverklaring Wellington" (Wellington Transparency Declaration) and explicitly references Article 14 of the Belgian law of May 2, 2007, regarding the disclosure of major shareholdings. It details a change in the shareholding percentage of Wellington Management Group LLP in UCB NV, specifically noting that their stake dropped below the 5% threshold on May 14, 2024. This type of mandatory disclosure concerning changes in significant ownership thresholds is classified as a Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS category.
2024-05-17 Dutch
170510 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Acquisition of own shares" and explicitly details the repurchase of UCB shares on Euronext Brussels between May 10, 2024, and May 16, 2024, under the Share Repurchase Program 2024. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate filing code is POS.
2024-05-17 English
170510 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share repurchase) and explicitly details the transactions made by UCB SA to repurchase its own shares on Euronext Brussels between May 10, 2024, and May 16, 2024. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing is a regulatory announcement ('Information réglementée') detailing these specific transactions, making the code POS the most appropriate classification.
2024-05-17 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.